Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Dis Esophagus ; 29(8): 1064-1070, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26401634

RESUMO

The purpose of this case-control study was to evaluate the impact of hybrid minimally invasive esophagectomy for cancer on surgical stress response and nutritional status. All 34 consecutive patients undergoing hybrid minimally invasive esophagectomy for cancer at our surgical unit between 2008 and 2013 were retrospectively compared with 34 patients undergoing esophagectomy with open gastric tubulization (open), matched for neoadjuvant therapy, pathological stage, gender and age. Demographic data, tumor features and postoperative course (including quality of life and systemic inflammatory and nutritional status) were compared. Postoperative course was similar in terms of complication rate. Length of stay in intensive care unit was shorter in patients undergoing hybrid minimally invasive esophagectomy (P = 0.002). In the first postoperative day, patients undergoing hybrid minimally invasive esophagectomy had lower C-reactive protein levels (P = 0.001) and white cell blood count (P = 0.05), and higher albumin serum level (P = 0.001). In this group, albumin remained higher also at third (P = 0.06) and seventh (P = 0.008) postoperative day, and C-reactive protein resulted lower at third post day (P = 0.04). Hybrid minimally invasive esophagectomy significantly improved the systemic inflammatory and catabolic response to surgical trauma, contributing to a shorter length of stay in intensive care unit.


Assuntos
Neoplasias Esofágicas/cirurgia , Esofagectomia/métodos , Idoso , Proteína C-Reativa , Estudos de Casos e Controles , Neoplasias Esofágicas/sangue , Feminino , Humanos , Tempo de Internação , Contagem de Leucócitos , Masculino , Pessoa de Meia-Idade , Procedimentos Cirúrgicos Minimamente Invasivos/métodos , Estado Nutricional , Período Pós-Operatório , Estudos Retrospectivos , Albumina Sérica , Resultado do Tratamento
2.
Rev Esp Med Nucl Imagen Mol ; 34(6): 378-82, 2015.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-26420439

RESUMO

Many open questions remain to be elucidated about the diagnosis, treatment and prognosis of medullary thyroid cancer (MTC). The most intriguing concerns the outcome of MTC patients after surgery. Great importance is usually given to serum calcitonin (Ct) and carcinoembryonic (CEA) levels. It is commonly believed that the higher are the levels of these tumor markers and their kinetics (double time and velocity of markers levels) the worst is the prognosis. However, this is not the rule, as there are huge MTC metastatic deposits characterized by low serum Ct and CEA levels, and this condition is not closely related to the outcome of the disease during post-surgical follow-up. A series is reported here of patients who have these characteristics, as well as a description of their prognosis and clinical outcome.


Assuntos
Calcitonina/sangue , Carcinoma Medular/sangue , Carcinoma Neuroendócrino/sangue , Hipercalcemia/etiologia , Neoplasias da Glândula Tireoide/sangue , Adenocarcinoma Folicular/diagnóstico , Adenocarcinoma Folicular/diagnóstico por imagem , Adenocarcinoma Folicular/patologia , Idoso , Biomarcadores Tumorais/sangue , Neoplasias Ósseas/diagnóstico por imagem , Neoplasias Ósseas/secundário , Carcinoma Medular/diagnóstico por imagem , Carcinoma Medular/genética , Carcinoma Medular/secundário , Carcinoma Medular/cirurgia , Carcinoma Neuroendócrino/diagnóstico por imagem , Carcinoma Neuroendócrino/genética , Carcinoma Neuroendócrino/cirurgia , Carcinoma Papilar/diagnóstico por imagem , Diagnóstico Tardio , Erros de Diagnóstico , Feminino , Humanos , Excisão de Linfonodo , Metástase Linfática , Masculino , Pessoa de Meia-Idade , Neoplasia Endócrina Múltipla Tipo 2a/sangue , Neoplasia Endócrina Múltipla Tipo 2a/genética , Mutação de Sentido Incorreto , Estadiamento de Neoplasias/métodos , Paraganglioma/diagnóstico por imagem , Paraganglioma/genética , Pentagastrina , Proteínas Proto-Oncogênicas c-ret/genética , Neoplasias da Glândula Tireoide/diagnóstico por imagem , Neoplasias da Glândula Tireoide/genética , Neoplasias da Glândula Tireoide/cirurgia , Tireoidectomia/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...